SEP 21, 2026 · JOURNAL ARTICLE
Opportunities in cancer gene therapy: inhibiting MDM2 and restoring p14ARF as a means to activate p53
Molecular and Cellular Biochemistry
Abstract The MDM2/p53/p14ARF axis represents a central regulatory network controlling cell-cycle progression, genomic stability, and tumor suppression, and is frequently deregulate